• Français
  • Webinar on rational drug use

    Drugs are considered an indicator of the quality of health care globally as they play a vital role in saving lives. For a sustainable healthcare service, it is mandatory to use medicines with regard to rational principles. Rational use of essential medicines can prevent, treat, or alleviate most leading causes of death and disability in developing countries and globally. The World Health Organization (WHO), defined rational use of medicines (RUM) as “Patients receive medications appropriate to their clinical needs, in doses that meet their own individual requirements, for an adequate period of time, and at the lowest cost to them and their community”.

    The role of governments, drug authorities, society, manufacturers, the educational system, media, patients and other health care workers cannot be denied as Rational drug Use (RDU) plays a vital role in avoiding preventable adverse drug effects, maximising therapeutic outcomes with promoting patient adherence and minimising the cost of drug therapy.

    The role of Faith based organisations is key in providing health care around the world ensuring that there is healing and wholeness of the human person thus supporting the church-based health services to better serve the poor, marginalised and unreached.

    Background

    In recent years, the number, variety, and use of medicines have dramatically increased. This increase has brought some affirmative improvements (i.e. new medication opportunities) but has also caused some serious healthcare problems attributed to irrational drug use. Evidence has shown that multi-drug prescribing, overprescribing, misuse of drugs, overuse of antibiotics and injections, treatment failures, drug resistance, medication errors, use of unnecessary expensive drugs, drug wastage, environmental pollution, increased mortality and morbidity, increased adverse drug reactions and hospitalisation, and wasted economical resources are most common problems of irrational drug use[1].

    According to Pan American Health Organisation and World Health Organisation, the promotion of rational use of medicines through policies, structures, information and education includes:

    1. A national body to coordinate policies on medicines use
    2. Evidence-based clinical guidelines for training, supervision and supporting decision-making
    3. Lists of essential medicines for medicine procurement and insurance reimbursement
    4. Medicines and therapeutics committees in districts and hospitals to monitor and implement interventions to improve the use of medicines
    5. Continuing medical education
    6. Independent and unbiased information about medicines for health personnel and consumers
    7. Elimination of financial incentives that lead to improper prescribing
    8. Regulations to ensure that promotional activities meet ethical criteria
    9. Adequate funding to ensure the availability of medicines and health personnel

    Furthermore, the knowledge required by physicians, patients and other people involved in the drug utilisation process increases day by day, in parallel with the increase in the knowledge about treatments and medicines. This situation brings along the lack of knowledge and information pollution and also contributes to irrational drug use.

    Communities also contribute to this problem through self-diagnosis and rampant over-the-counter dispensing of antibiotics.

    EPN has put in place this webinar as an information sharing activity to exchange experiences and best practices among members, an essential approach to strengthening pharmaceutical services in church health facilities. The webinar will discuss some of the effects of irrational drug use from key players in the health sector as well as approaches being implemented to promote rational drug use while addressing how to curb some of the constant challenges on the ground.

    Rational

    The key aim of this webinar is

    1. To promote a culture of Rational Drug Use
    2. To Empower healthcare workers to successfully manage and implement interventions that respond to rational rational medicine use
    3. Identify gaps that can be addressed
    4. To highlight the importance of data collection and data driven research.
    5. To highlight the importance of laboratory testing when prescribing drugs to patients.
    6. Enable participants to gain a deeper understanding of effects of irrational drug use with a focus on drug resistance.
    7. Provide a platform for knowledge sharing on best practices that promote rational drug use.
    Outcomes
    1. Strengthening systems to promote Rational Drug Use
    2. To give members voice to share their day to day experiences and contributions
    3. To enable member to promote a culture of Rational Drug Use

     

    This webinar will respond to some of the following questions:

    1. The role of advocacy in promoting Rational Drug Use
    2. How do Faith – based organisations contribute to promote Rational Drug Use?
    3. Advances in research and development
    4. Pharmaceutical care services and patient centred care
    5. Importance of formation of Medicine Therapeutic Committees
    6. Management of drugs (storage, prescribing, expiry and disposal)
    7. Most prescribers allow themselves to be influenced by medical sales representatives
    8. Alternative methods/ holistic approach
    Reference
    1. [1] https://www.who.int/activities/promoting-rational-use-of-medicines
    2. 2Donna Kusemerewa, Health Action International; Kusemewera, D. (2012). Mission Sector.
    3. The Politics of Medicines (e-Encyclopaedia); https://haiweb.org/encyclopaedia/mission-sector/
    4. 3Rational Use of Medicines and Other Health Technologies; https://www.paho.org/en/topics/rational-use-medicines-and-other-health-technologies
    5. 4Jain S, Upadhyaya P, Goyal J, et al. A systematic review of prescription pattern monitoring studies and their effectiveness in promoting rational use of medicines. Perspect Clin Res. 2015;6(2):86. doi: 10.4103/2229-3485.154005
    Program

    The webinar has been scheduled to take place  on 27th April 2023 from:

    1. 13:30 – 15:00 EAT
    2. 12:30 – 14:00 CAT
    3. 11:30 – 13:00 WAT

    EPN encourages you and your affiliated health facilities to join and participate.

    Moderator: Dr. Judith Asin, Program Officer, Pharmaceutical Systems Strengthening (PSS), EPN

    English-French Interpreter: Mike Upio, Public Health Expert and EPN Individual member

    Speakers:

    1. Winnie Wanjiku, Clinical pharmacist Kenyatta University Teaching, Referral & Research Hospital (KUTRRH)
    2. Regulatory body Representative from Malawi
    3. Trupti Rekha Swain, Professor & Head of the Department of Pharmacology, SCB Medical College, Cuttack, Odisha, India and Pharmaceutical Advisor, CDMU Community Development Medicinal Unit ODISHA (CDMUO)
    4. Macford Chandalala, Pharmaceutical and Logistics Services Manager, Churches Health Association of Zambia (CHAZ) Representative